The Impact of Chitinase Binding Domain Truncation on the Properties of CaChi18B from Chitinilyticum aquatile CSC-1
Marine Drugs · 2025
DOI: 10.3390/md23030093 ↗Kurz gefasst
Fachartikel in der Zeitschrift Marine Drugs, 2025. Verfasst von Chenxi Gu und 7 weiteren Autor:innen. Beteiligte Einrichtung: Guangxi Key Laboratory for Polysaccharide Materials and Modifications, School of Marine Sciences and Biotechnology, Guangxi Minzu University, Nanning…. Hauptthemen laut MEDLINE: Betaproteobacteria, Chitinases, Bacterial Proteins, Chitin. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 67 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Guangxi Science and Technology Base and Talent Project, Science and Technology Major Project of Guangxi, National Natural Science Foundation of China.
Abstract (Originalsprache)
The chitinase binding domain (ChBD) plays a crucial role in the properties of enzymes. To assess its impact, we cloned a truncated mutant of the chitinase gene CaChi18B from the novel chitinase-producing facultative anaerobic bacterium Chitinilyticum aquatile CSC-1, designated as CaChi18B_ΔChBDs. The recombinant chitinase was successfully expressed and purified, exhibiting a specific activity of 3.48 U/mg on colloidal chitin, with optimal conditions at 45 °C and pH 6.0, and retaining over 80% activity at temperatures up to 40 °C. Kinetic analysis revealed that the Km value was 1.159 mg mL−1 and the Vmax was 10.37 μM min−1 mg−1. Compared to CaChi18B_ΔChBD1, which has only the first ChBD truncated at the N-terminus, CaChi18B_ΔChBDs exhibited minor changes in the optimal temperature and pH, while the Km and Vmax values increased significantly. CaChi18B_ΔChBDs exhibited tolerance to various metal ions, with K+ and NH4+ enhancing activity, while Cu2+ significantly inhibited it. Most organic reagents had minimal impact, except for formic acid, which severely reduced activity. The primary hydrolysis product in the initial phase was GlcNAc, contrasting with (GlcNAc)2 for CaChi18B_ΔChBD1. These findings indicated that the ChBD influences the enzyme’s Km, Vmax, and product distribution, enhancing our understanding of ChBD’s roles and advancing chitin utilization.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Guangxi Key Laboratory for Polysaccharide Materials and Modifications, School of Marine Sciences and Biotechnology, Guangxi Minzu University, Nanning 530008, China.
- National Key Laboratory of Non-Food Biomass Energy Technology, Guangxi Key Laboratory of Marine Natural Products and Combinatorial Biosynthesis Chemistry, Guangxi Academy of Marine Sciences, Guangxi Academy of Sciences,…
- Institute of Biology, Guangxi Academy of Sciences, Nanning 530007, China.
ORCID-Profile: Dengfeng Yang, Lixia Pan
Förderung
- Guangxi Science and Technology Base and Talent Project
- Science and Technology Major Project of Guangxi
- National Natural Science Foundation of China
- Innovation and Development fund of Guangxi Academy of Sciences
- Basic Science and Research Foundation of Guangxi Academy of Sciences
- Innovation and Development Fund of the Guangxi Academy of Sciences
- Basic Science and Research Foundation of the Guangxi Academy of Sciences
Zitieren
APA
Gu, C., Chen, J., Huang, X., Jiang, Y., Ou, N., Yang, D., Jiang, M., & Pan, L. (2025). The Impact of Chitinase Binding Domain Truncation on the Properties of CaChi18B from Chitinilyticum aquatile CSC-1. Marine Drugs. https://doi.org/10.3390/md23030093
Vancouver
Gu C, Chen J, Huang X, Jiang Y, Ou N, Yang D, et al. The Impact of Chitinase Binding Domain Truncation on the Properties of CaChi18B from Chitinilyticum aquatile CSC-1. Marine Drugs. 2025. doi:10.3390/md23030093
BibTeX
@article{Gu2025,
author = {Gu, Chenxi and Chen, Jianrong and Huang, Xinyue and Jiang, Yongqiang and Ou, Na and Yang, Dengfeng and Jiang, Mingguo and Pan, Lixia},
title = {The Impact of Chitinase Binding Domain Truncation on the Properties of CaChi18B from Chitinilyticum aquatile CSC-1},
journal = {Marine Drugs},
year = {2025},
doi = {10.3390/md23030093}
}
EUVIMED